MoneyTechCrunch
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Join the argument
House rules →Comments load as you scroll.